Silver-stained nucleolar organizer regions (AgNORS) as a prognostic value in malignant melanoma

American Journal of Dermatopathology

Volumn 20, Issue 5, 1998, Pages 473-477

  Barzilai, Aviv ^a   Goldberg, Iris ^a   Yulash, Michael ^a   Pavlotsky, Felix ^a   Zuckerman, Avraham ^b   Trau, Henri ^a   Azizi, Esther ^a   Kopolovic, Juri ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b Biological Institute   (Israel)

Author keywords

Disease free interval; Malignant melanoma; Nucleolar organizer regions

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME NOR; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SILVER STAINING; SKIN BIOPSY; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NUCLEOLUS ORGANIZER REGION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SILVER STAINING; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031692807     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199810000-00008     Document Type: Article

References (19)

1. Troster H, Spring H, Meissner B, Schultz P, Oudet P, Trendelemburg MF. Structural organization of an active, chromosomal nucleolar organizer region (NOR) identified by light microscopy and subsequent TEM and STEM electron microscopy. Chromosoma 1985;91:151-63.
2. Stahl A. The nucleolus and nucleolar chromosomes. In: Jordan EG, Cullis CA, eds. The nucleolus. London: Cambridge University, 1982:1-24.
3. Crocker J. Nucleolar organizer regions. In: Underwood JCE, ed. Current topics in pathology. New York: Springer-Verlag, 1990: 91-150.
4. Gambini C, Casazza S, Borgiani L, et al. Counting the nucleolar organizer region - associated proteins is a prognostic clue of malignant melanoma. Arch Dermatol 1992;128:487-90.
5. Howat AJ, Giri DD, Wright AL, Underwood JCE. Silver stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. J Pathol 1988;156: 227-32.
6. Evans AT, Blessing K, Orrell JM, Grant A. Mitotic indices, anti PCNA immunostaining, and AgNORs in thick cutaneous melanoma displaying paradoxical behaviour. J Pathol 1992;168:15-22.
7. Paridanes AD, Seregard S, Minassian D, Hungerford JL, McCortney ACE. AgNOR counts in conjunctival malignant melanoma lack prognostic value. Br J Ophthalmol 1992;76:621-3.
8. Ronan SG, Farolan JR, Manaligod AL, Shilkaitis AL, Kim DK, Das Gupta DK. Proliferative activity in thick cutaneous malignant melanoma [Abstract]. J Cutan Pathol 1996;23:91.
9. Malignant melanoma of the skin (excluding eyelid). In: Beahrs OH, Henson DE, Hutter RVP, et al., eds. American Joint Committee on Cancer Manual for Staging of Cancer. 4th ed. Philadelphia: JB Lippincott, 1992:143-8.
10. Papa MZ, Klein E, Karni T, et al. Regional hyperthermic perfusion with cisplatinum following surgery for malignant melanoma of the extremities. Am J Surg 1996;171:416-20.
11. Azizi E, Brenner HJ, Shoham J. Postsurgical adjuvant treatment of malignant melanoma patients by the thymic factor thymostimulin. Drug Res 1984;34:1043-6.
12. Lever WF, Schaumberg-Lever G. Histopathology of the skin. Philadelphia: JB Lippincott, 1990:780-805.
13. Fogt F, Vortmeyer AO, Tahan SR. Nuclear organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions. Am J Dermatopathol 1995;17:12-17.
14. Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ, Kenet RO, Koh HK. Neoplasm: malignant melanoma. In: Fitzpatrick TB, Eisen AZ, Wolf K, et al., eds. Dermatology in general medicine. New York: McGraw-Hill, 1993:1078-115.
15. Johnson TM, Smith JW II, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995;32:689-707.
16. Croker J, Boldy DAR, Egan MT. How should we count AgNORs? Proposal for standardized approach. J Pathol 1989;158:185-8.
17. Roschoff T, Plate KH, Contractor H, Kenn S, Zimmermann R, Thomas C. Evaluation of nucleolar organizer regions (NORs) by automatic image analysis: a contribution to standardization. J Pathol 1990;161:113-8.
18. Gonzalez AP, Kumar D, Snachez RL. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting. Am J Dermatopathol 1994;16: 372-6.
19. Barzilai A, Goldberg I, Yulash M, et al. Evaluation of the nucleolar organizer regions in malignant melanoma [Abstract]. J Cutan Pathol 1996;23:66.